Vaccinex (VCNX) SEC Filings & 10K Form

$5.62
+0.12 (+2.18%)
(As of 05/15/2024 ET)

Recent Vaccinex SEC Filings

DateFilerForm TypeView
05/12/2024
11:15 PM
Vaccinex (Filer)
Form EFFECT
05/09/2024
4:08 PM
Vaccinex (Filer)
Form 424B3
05/08/2024
11:29 AM
Vaccinex (Filer)
Form S-3/A
04/26/2024
4:16 PM
Vaccinex (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/25/2024
2:00 PM
Vaccinex (Filer)
Form 10-K/A
04/22/2024
3:33 PM
FCMI Parent Co. (Reporting)
FRIEDBERG ALBERT (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
11:15 PM
Vaccinex (Filer)
Form EFFECT
04/16/2024
3:55 PM
Vaccinex (Filer)
Form 424B3
04/12/2024
3:25 PM
Vaccinex (Filer)
Form D
Notice of Exempt Offering of Securities 
04/12/2024
3:15 PM
Vaccinex (Filer)
Form D
Notice of Exempt Offering of Securities 
04/02/2024
3:23 PM
Vaccinex (Filer)
Form DEF 14A
04/02/2024
3:11 PM
Vaccinex (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/01/2024
7:53 PM
FCMI Parent Co. (Reporting)
FRIEDBERG ALBERT (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
7:54 PM
Vaccinex , L.L.C. (0001747866) (Reporting)
Vaccinex (Issuer)
Zauderer Maurice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:54 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
12:27 PM
Vaccinex (Filer)
Form 424B5
03/27/2024
7:39 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
3:31 PM
Vaccinex (Issuer)
Zauderer Maurice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:31 PM
Sanchez Jill (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:32 PM
Smith Ernest S. (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:33 PM
Evans Elizabeth E. (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
3:31 PM
Sanchez Jill (Reporting)
Vaccinex (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/04/2024
3:19 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
9:10 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
7:06 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
3:32 PM
FCMI Parent Co. (Reporting)
FRIEDBERG ALBERT (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
3:34 PM
Vaccinex , L.L.C. (0001747866) (Reporting)
Vaccinex (Issuer)
Zauderer Maurice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
7:20 AM
Vaccinex (Filer)
Form 8-K/A
02/07/2024
5:55 PM
HIRSCHMAN ORIN (Filed by)
Vaccinex (Subject)
Form SC 13G/A
02/07/2024
2:43 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2024
11:15 PM
Vaccinex (Filer)
Form EFFECT
01/19/2024
3:40 PM
Vaccinex (Filer)
Form 424B3
01/10/2024
4:16 PM
Vaccinex (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2024
3:16 PM
Vaccinex (Filer)
Form DEF 14A
12/28/2023
3:31 PM
Vaccinex (Issuer)
Van Strydonck, Gerald E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:15 PM
Vaccinex (Filer)
Form PRE 14A
12/12/2023
3:31 PM
Vaccinex (Issuer)
Van Strydonck, Gerald E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
6:46 AM
Vaccinex (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
8:30 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2023
3:30 PM
Frieberg Jacob B. (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
3:15 PM
FCMI Parent Co. (Filed by)
Vaccinex (Subject)
Form SC 13D/A
This unknown company solves the biggest issue with AI (Ad)

Nvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in.

Discover why this company
10/13/2023
3:54 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
3:30 PM
Vaccinex (Subject)
Zauderer Maurice (Filed by)
Form SC 13D/A
10/11/2023
11:28 AM
HIRSCHMAN ORIN (Filed by)
Vaccinex (Subject)
Form SC 13G
10/05/2023
3:30 PM
Frieberg Jacob B. (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
3:30 PM
FCMI Parent Co. (Reporting)
FRIEDBERG ALBERT (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
3:31 PM
Vaccinex , L.L.C. (0001747866) (Reporting)
Vaccinex (Issuer)
Zauderer Maurice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
8:20 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2023
8:16 AM
Vaccinex (Filer)
Form 424B4
09/28/2023
11:15 PM
Vaccinex (Filer)
Form EFFECT
09/28/2023
7:41 PM
Vaccinex (Filer)
Form S-1MEF
09/27/2023
7:00 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
3:15 PM
Vaccinex (Subject)
Zauderer Maurice (Filed by)
Form SC 13D/A
09/26/2023
7:01 AM
Vaccinex (Filer)
Form S-1/A
09/26/2023
7:06 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:12 PM
Vaccinex (Issuer)
Zauderer Maurice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:37 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
3:21 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
4:26 PM
Vaccinex (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/13/2023
5:46 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2023
3:31 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
7:01 AM
Vaccinex (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2023
11:15 PM
Vaccinex (Filer)
Form EFFECT
07/11/2023
5:04 AM
Vaccinex (Filer)
Form 424B3
06/14/2023
4:03 PM
Vaccinex (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/30/2023
7:50 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2023
4:13 PM
Vaccinex (Filer)
Form 424B5
05/19/2023
4:15 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VCNX) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners